| 1 |
35214025 | Targeted Self-Emulsifying Drug Delivery Systems to Restore Docetaxel Sensitivity in Resistant Tumors. | 2022 Jan 26 |
2 |
| 2 |
26548759 | Targeting ABCB1 and ABCC1 with their Specific Inhibitor CBT-1® can Overcome Drug Resistance in Osteosarcoma. | 2016 |
1 |
| 3 |
27284014 | Multiplicity of acquired cross-resistance in paclitaxel-resistant cancer cells is associated with feedback control of TUBB3 via FOXO3a-mediated ABCB1 regulation. | 2016 Jun 7 |
1 |
| 4 |
16644109 | Docetaxel-induced growth inhibition and apoptosis in androgen independent prostate cancer cells are enhanced by 1alpha,25-dihydroxyvitamin D3. | 2007 Mar 8 |
1 |
| 5 |
15256465 | Analysis of the drug resistance profile of multidrug resistance protein 7 (ABCC10): resistance to docetaxel. | 2004 Jul 15 |
1 |
| 6 |
15298732 | Docetaxel enhances the cytotoxicity of cisplatin to gastric cancer cells by modification of intracellular platinum metabolism. | 2004 Aug |
2 |
| 7 |
14617793 | Taxane-based reversal agents modulate drug resistance mediated by P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein. | 2003 Nov |
1 |
| 8 |
10405640 | Cytoskeletons and antimitotic agents developed in Japan. | 1999 Apr |
1 |
| 9 |
9496387 | Comparative antitumor efficacy of docetaxel and paclitaxel in nude mice bearing human tumor xenografts that overexpress the multidrug resistance protein (MRP) | 1997 Dec |
5 |